Researchers at Eindhoven University of Technology (TU/e) present a new method that should enable controlled drug delivery into the bloodstream using DNA computers. In the journal Nature Communications the team, led by biomedical engineer Maarten Merkx, describes how it has developed the first DNA computer capable of detecting several antibodies in the blood and performing subsequent calculations based on this input. This is an important step towards the development of smart, ‘intelligent’ drugs that may allow better control of the medication for rheumatism and Crohn’s disease, for example, with fewer side-effects and at lower cost.
An analogy for the method presented by the TU/e researchers is a security system that opens the door depending on the person standing in front of it. If the camera recognizes the person, the door unlocks, but if the person is unknown, the door remains locked. “Research into diagnostic tests tends to focus on the ‘recognition’, but what is special about this system is that it can think and that it can be connected to actuation such as drug delivery,” says professor of Biomedical Chemistry Maarten Merkx.
To be able to perform such an action, ‘intelligence’ is needed, a role that is performed in this system by a DNA computer. DNA is best known as a carrier of genetic information, but DNA molecules are also highly suitable for performing molecular calculations. The sequence within a DNA molecule determines with which other DNA molecules it can react, which allows a researcher to program desired reaction circuits.
To date biomedical applications of DNA computers have been limited because the input of DNA computers typically consists of other DNA and RNA molecules. To determine whether someone has a particular disease, it is essential to measure the concentration of specific antibodies – agents that our immune system produces when we are ill. Merkx and his colleagues are the first to have succeeded in linking the presence of antibodies to a DNA computer.
Their method translates the presence of each antibody into a unique piece of DNA whereby the DNA computer can decide on the basis of the presence of one or more antibodies whether drug delivery, for example, is necessary. “The presence of a particular DNA molecule sets in motion a series of reactions whereby we can get the DNA computer to run various programs,” explains PhD student and primary author Wouter Engelen. “Our results show that we can use the DNA computer to control the activity of enzymes, but we think it should also be possible to control the activity of a therapeutic antibody.”
In treating chronic diseases like rheumatism or Crohn’s disease, such therapeutic antibodies are used as medication. One of the potential applications of this system is to measure the quantity of therapeutic antibodies in the blood and decide whether it is necessary to administer any extra medication. Merkx: “By directly linking the measurement of antibodies to the treatment of the disease, we may be able to prevent side-effects and reduce costs in the future.”
Receive an email update when we add a new INTELLIGENT DRUGS article.
The Latest on: Intelligent drugs
via Google News
The Latest on: Intelligent drugs
- 'Your parents will never look at you the same way again' - 21-year-old from 'loving home' jailed for drug dealingon October 17, 2019 at 10:30 pm
"It was all so pointless and avoidable. You are such a bright and intelligent man, I can't believe you are not aware of the harmful effects these poisons have. "The lives ruined by drugs in this case ...
- Senti Biosciences Announces Dr. Brenda Cooperstone as New Independent Board Memberon October 17, 2019 at 5:47 pm
Leading gene circuit company recruits experienced drug developer for board of directors’ position to help steward clinical translation of gene circuit therapies Senti Biosciences, the leading gene ...
- SA biotech makes deal with New York firm to design fat-reduction deviceon October 17, 2019 at 12:19 pm
has teamed with Intelligent Product Solutions, a subsidiary of Forward Industries (Nasdaq: FORD), which will design its abdominal fat reduction device. The new alliance follows confirmation from ...
- Health Intelligent Virtual Assistant Market 2018-2026 to Post 34% CAGR | AcumenRCon October 17, 2019 at 6:09 am
The report analyses the recent drug approval trends and market dynamics such as drivers, restrains, and opportunities, industry trends and future outlook in this market research report. Scope of the ...
- Fingerprint drug testing boosts family safeguardingon October 16, 2019 at 4:32 am
Fingerprint-based drug testing from a Cambridge company is being used by Peterborough City Council as part of its family safeguarding social care initiative. Following a successful trial of the ...
- Peterborough is the first council to roll out fingerprint drug testing for family safeguardingon October 15, 2019 at 9:20 am
The Intelligent Fingerprinting portable analysis unit then reads the cartridge and provides a positive or negative result on-screen for all drugs in the test in 10 minutes Peterborough City Council ...
- Bill Turnbull calls for cannabis law changes after taking drug amid cancer battleon October 15, 2019 at 2:31 am
Bill Turnbull takes cannabis in his new documentary (Picture: Channel 4) Bill Turnbull believes there should be changes to the law surrounding medicinal cannabis after taking the drug for a new ...
- Active & Intelligent Packaging Market 2019 Global Key Players, Size, Applications & Growth Opportunities – Analysis to 2024on October 14, 2019 at 5:30 am
The pharmaceutical sector can boost the market with its application to transfer drugs to distant corners. However, the market for active and intelligent packaging can face some hindrances in the shape ...
- Hustlers with Jennifer Lopez and Constance Wu as strippers is intelligent and entertainingon October 13, 2019 at 3:51 pm
It arguably does in Hustlers. Lorene Scafaria does double duty on this film, based on a New York magazine article. It's an absorbing story of strippers, strip-club patrons, crime and drugs that could ...
via Bing News